Mereo BioPharma Group PLC (LTS:0A9G)
$ 4.0269 -0.0681 (-1.66%) Market Cap: 623.10 Mil Enterprise Value: 541.83 Mil PE Ratio: 0 PB Ratio: 7.88 GF Score: 28/100

Half Year 2020 Mereo BioPharma Group plc Earnings Call Transcript

Sep 29, 2020 / 12:00PM GMT
Operator

Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Mereo BioPharma 2020 Interim Results Conference Call. (Operator Instructions) It is now my pleasure to turn the call over to Steve Klass, Vice President with Burns McClellan. Please go ahead, sir.

Steve Klass
Burns McClellan - IR

Thank you, operator. Good morning, everyone. Good afternoon to those of you in the UK and thank you for joining Mereo's 2020 interim financial results and corporate update conference call. Earlier today, the company issued a press release providing an overview of recent business progress as well as financial results for the six months ended June 30, 2020. This press release may be accessed on the Investors portion of Mereo's website at www.mereobiopharma.com.

Leading the call today will be Dr. Denise Scots-Knight, Mereo's Chief Executive Officer, who will provide a summary of the Company's recent clinical and corporate developments. Afterward, Michael Wyzga, Interim CFO of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot